Implanted ports in adults with primary immunodeficiency.

CONCLUSION: The utility and safety of implanted ports in adults with primary immune deficiency for whom subcutaneous immunoglobulin G therapy is not desired or feasible are probably similar to those of ports in patients without primary immune deficiency. PMID: 29542377 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29542377?dopt=Abstract

Source: The Journal of Vascular Access - March 18, 2018 Category: Surgery Tags: J Vasc Access Source Type: research